MainReads
← Details
Impact of extramedullary plasmacytoma on outcomes in patients with relapsed refractory multiple myeloma treated with talquetamab: U.S. Myeloma Immunotherapy Consortium.
Afrough A, Pasvolsky O, Portuguese AJ, Zanwar S, Gaballa MR, Sannareddy A, Dima D, Goel U, Ali HM, Julian K, De Menezes Silva Corraes A, Janakiram M, Goldsmith S, Davis JA, Green K, Biran N, Fogel L, Zolotov E, Herr MM, Hassan H, Shune L, Kort J, Ye C, Bal S, Costa LJ, Joiner L, Al Hadidi S, Khan AM, Raza S, Anwer F, Khouri J, Banerjee R, Cassano Cassano R, Sidana S, Rana MS, Mikkilineni L, Hosoya H, Atrash S, Ferreri C, Varga C, Sborov DW, Midha S, Nadeem O, Grajales-Cruz A, Baz R, Blue B, Freeman C, Locke FL, Patel KK, Lin Y, Kumar SK, Hansen DK, Anderson LD Jr, Voorhees PM, Castaneda-Puglianini O
/
-
Loading document from repository...
Unable to Display Document
The online reader was unable to display this document directly. This may occur if the repository host is temporarily unreachable, or if security restrictions (CORS) prevent embedded viewing.